S&P 500   3,325.54 (+0.11%)
DOW   29,160.09 (-0.09%)
QQQ   224.59 (+0.32%)
AAPL   319.23 (+0.48%)
FB   219.76 (-0.70%)
MSFT   166.72 (+0.62%)
GOOGL   1,484.69 (+0.04%)
AMZN   1,884.58 (-0.15%)
CGC   24.56 (+1.82%)
NVDA   252.86 (+1.12%)
BABA   219.13 (-1.46%)
MU   59.20 (+0.05%)
GE   11.77 (+3.52%)
TSLA   572.20 (+0.46%)
AMD   51.71 (+0.54%)
T   38.63 (-1.05%)
ACB   2.07 (+1.47%)
F   9.14 (-0.22%)
NFLX   349.60 (+7.24%)
BAC   34.12 (-0.70%)
DIS   142.20 (-1.26%)
GILD   63.94 (+0.80%)
S&P 500   3,325.54 (+0.11%)
DOW   29,160.09 (-0.09%)
QQQ   224.59 (+0.32%)
AAPL   319.23 (+0.48%)
FB   219.76 (-0.70%)
MSFT   166.72 (+0.62%)
GOOGL   1,484.69 (+0.04%)
AMZN   1,884.58 (-0.15%)
CGC   24.56 (+1.82%)
NVDA   252.86 (+1.12%)
BABA   219.13 (-1.46%)
MU   59.20 (+0.05%)
GE   11.77 (+3.52%)
TSLA   572.20 (+0.46%)
AMD   51.71 (+0.54%)
T   38.63 (-1.05%)
ACB   2.07 (+1.47%)
F   9.14 (-0.22%)
NFLX   349.60 (+7.24%)
BAC   34.12 (-0.70%)
DIS   142.20 (-1.26%)
GILD   63.94 (+0.80%)
S&P 500   3,325.54 (+0.11%)
DOW   29,160.09 (-0.09%)
QQQ   224.59 (+0.32%)
AAPL   319.23 (+0.48%)
FB   219.76 (-0.70%)
MSFT   166.72 (+0.62%)
GOOGL   1,484.69 (+0.04%)
AMZN   1,884.58 (-0.15%)
CGC   24.56 (+1.82%)
NVDA   252.86 (+1.12%)
BABA   219.13 (-1.46%)
MU   59.20 (+0.05%)
GE   11.77 (+3.52%)
TSLA   572.20 (+0.46%)
AMD   51.71 (+0.54%)
T   38.63 (-1.05%)
ACB   2.07 (+1.47%)
F   9.14 (-0.22%)
NFLX   349.60 (+7.24%)
BAC   34.12 (-0.70%)
DIS   142.20 (-1.26%)
GILD   63.94 (+0.80%)
S&P 500   3,325.54 (+0.11%)
DOW   29,160.09 (-0.09%)
QQQ   224.59 (+0.32%)
AAPL   319.23 (+0.48%)
FB   219.76 (-0.70%)
MSFT   166.72 (+0.62%)
GOOGL   1,484.69 (+0.04%)
AMZN   1,884.58 (-0.15%)
CGC   24.56 (+1.82%)
NVDA   252.86 (+1.12%)
BABA   219.13 (-1.46%)
MU   59.20 (+0.05%)
GE   11.77 (+3.52%)
TSLA   572.20 (+0.46%)
AMD   51.71 (+0.54%)
T   38.63 (-1.05%)
ACB   2.07 (+1.47%)
F   9.14 (-0.22%)
NFLX   349.60 (+7.24%)
BAC   34.12 (-0.70%)
DIS   142.20 (-1.26%)
GILD   63.94 (+0.80%)
Log in
(Ad)
Paul Mampilly correctly predicted every bull and bear market over the last two decades. He made millions. His new "Dow 100,000" prediction is his boldest yet. Even more stunning... Paul reveals how you could make millions as it unfolds.

NYSE:USPH - U.S. Physical Therapy Stock Price, Forecast & News

$120.30
+0.08 (+0.07 %)
(As of 01/23/2020 04:00 PM ET)
Today's Range
$119.28
Now: $120.30
$121.70
50-Day Range
$112.94
MA: $116.45
$121.39
52-Week Range
$102.92
Now: $120.30
$148.48
Volume69,700 shs
Average Volume91,047 shs
Market Capitalization$1.54 billion
P/E Ratio51.63
Dividend Yield1.00%
Beta1.03
U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The company provides industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors As of March 14, 2019, it operated 592 outpatient physical therapy clinics in 42 states; and managed 28 physical therapy facilities for unaffiliated third parties, including hospitals and physician groups. Read More…

Industry, Sector and Symbol

Industry Health services
Sub-IndustryHealth Care Facilities
SectorMedical
CUSIP90337L10
Phone713-297-7000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$453.91 million
Cash Flow$3.41 per share
Book Value$17.10 per share

Profitability

Net Income$34.87 million

Miscellaneous

Employees4,600
Market Cap$1.54 billion
Next Earnings Date2/27/2020 (Confirmed)
OptionableOptionable

Receive USPH News and Ratings via Email

Sign-up to receive the latest news and ratings for USPH and its competitors with MarketBeat's FREE daily newsletter.


(Ad)

If you're looking to potentially make 1,000% in gains, then you NEED this biotech stock. This company discovered a medical breakthrough that may end heart attacks FOREVER! Estimated annual sales are $60 billion. The FDA has all but said it's going to approve the drug. Once that happens, the stock price could double overnight. But you must be onboard BEFORE FDA approval.

U.S. Physical Therapy (NYSE:USPH) Frequently Asked Questions

What is U.S. Physical Therapy's stock symbol?

U.S. Physical Therapy trades on the New York Stock Exchange (NYSE) under the ticker symbol "USPH."

How often does U.S. Physical Therapy pay dividends? What is the dividend yield for U.S. Physical Therapy?

U.S. Physical Therapy announced a quarterly dividend on Thursday, November 7th. Stockholders of record on Monday, November 18th will be given a dividend of $0.30 per share on Friday, December 13th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.00%. The ex-dividend date is Friday, November 15th. View U.S. Physical Therapy's Dividend History.

How were U.S. Physical Therapy's earnings last quarter?

U.S. Physical Therapy, Inc. (NYSE:USPH) released its quarterly earnings data on Thursday, November, 7th. The company reported $0.71 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.71. The company earned $117.30 million during the quarter, compared to analyst estimates of $121.28 million. U.S. Physical Therapy had a return on equity of 16.57% and a net margin of 6.36%. U.S. Physical Therapy's revenue for the quarter was up 3.7% on a year-over-year basis. During the same quarter last year, the firm earned $0.64 EPS. View U.S. Physical Therapy's Earnings History.

When is U.S. Physical Therapy's next earnings date?

U.S. Physical Therapy is scheduled to release their next quarterly earnings announcement on Thursday, February 27th 2020. View Earnings Estimates for U.S. Physical Therapy.

How can I listen to U.S. Physical Therapy's earnings call?

U.S. Physical Therapy will be holding an earnings conference call on Thursday, February 27th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

What guidance has U.S. Physical Therapy issued on next quarter's earnings?

U.S. Physical Therapy updated its FY 2019 Pre-Market earnings guidance on Monday, November, 25th. The company provided EPS guidance of $2.80-2.90 for the period, compared to the Thomson Reuters consensus estimate of $2.94.

What price target have analysts set for USPH?

2 Wall Street analysts have issued 1 year price objectives for U.S. Physical Therapy's shares. Their forecasts range from $106.61 to $130.00. On average, they expect U.S. Physical Therapy's stock price to reach $118.31 in the next twelve months. This suggests that the stock has a possible downside of 1.7%. View Analyst Price Targets for U.S. Physical Therapy.

What is the consensus analysts' recommendation for U.S. Physical Therapy?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for U.S. Physical Therapy in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for U.S. Physical Therapy.

Has U.S. Physical Therapy been receiving favorable news coverage?

News headlines about USPH stock have been trending somewhat positive recently, according to InfoTrie Sentiment. InfoTrie rates the sentiment of news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. U.S. Physical Therapy earned a daily sentiment score of 0.8 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the stock's share price in the near term. View News Stories for U.S. Physical Therapy.

Are investors shorting U.S. Physical Therapy?

U.S. Physical Therapy saw a drop in short interest during the month of December. As of December 31st, there was short interest totalling 994,500 shares, a drop of 7.1% from the December 15th total of 1,070,000 shares. Based on an average daily volume of 101,900 shares, the short-interest ratio is presently 9.8 days. Approximately 7.9% of the shares of the stock are short sold. View U.S. Physical Therapy's Current Options Chain.

Who are some of U.S. Physical Therapy's key competitors?

What other stocks do shareholders of U.S. Physical Therapy own?

Based on aggregate information from My MarketBeat watchlists, some companies that other U.S. Physical Therapy investors own include Pfizer (PFE), Gilead Sciences (GILD), AbbVie (ABBV), Allergan (AGN), Marathon Petroleum (MPC), UnitedHealth Group (UNH), Cisco Systems (CSCO), PepsiCo (PEP), Starbucks (SBUX) and Walgreens Boots Alliance (WBA).

Who are U.S. Physical Therapy's key executives?

U.S. Physical Therapy's management team includes the folowing people:
  • Mr. Christopher J. Reading, Pres, CEO & Director (Age 55)
  • Mr. Lawrance W. McAfee, Exec. VP, CFO & Director (Age 64)
  • Mr. Glenn D. McDowell, Chief Operating Officer of West (Age 62)
  • Mr. Graham Reeve M.B.A., P.T., Chief Operating Officer of East (Age 55)
  • Mr. Jon C. Bates, VP & Corp. Controller

Who are U.S. Physical Therapy's major shareholders?

U.S. Physical Therapy's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Riverbridge Partners LLC (2.92%), Boston Trust Walden Corp (0.94%), Scout Investments Inc. (0.75%), State of Alaska Department of Revenue (0.08%), Louisiana State Employees Retirement System (0.03%) and We Are One Seven LLC (0.02%). Company insiders that own U.S. Physical Therapy stock include Bernard A Harris Jr, Christopher J Reading, Clayton Trier, Edward L Kuntz, Glenn Mcdowell, Graham D Reeve, Harry S Chapman, Jerald L Pullins, Kathleen A Gilmartin, Lawrance W Mcafee, Mark J Brookner and Regg E Swanson. View Institutional Ownership Trends for U.S. Physical Therapy.

Which major investors are selling U.S. Physical Therapy stock?

USPH stock was sold by a variety of institutional investors in the last quarter, including Riverbridge Partners LLC, Scout Investments Inc., AE Wealth Management LLC, Louisiana State Employees Retirement System, State of Alaska Department of Revenue and We Are One Seven LLC. Company insiders that have sold U.S. Physical Therapy company stock in the last year include Christopher J Reading, Clayton Trier, Glenn Mcdowell, Graham D Reeve, Lawrance W Mcafee and Mark J Brookner. View Insider Buying and Selling for U.S. Physical Therapy.

Which major investors are buying U.S. Physical Therapy stock?

USPH stock was acquired by a variety of institutional investors in the last quarter, including Boston Trust Walden Corp and Squar Milner Financial Services LLC. Company insiders that have bought U.S. Physical Therapy stock in the last two years include Harry S Chapman, Kathleen A Gilmartin and Regg E Swanson. View Insider Buying and Selling for U.S. Physical Therapy.

How do I buy shares of U.S. Physical Therapy?

Shares of USPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is U.S. Physical Therapy's stock price today?

One share of USPH stock can currently be purchased for approximately $120.30.

How big of a company is U.S. Physical Therapy?

U.S. Physical Therapy has a market capitalization of $1.54 billion and generates $453.91 million in revenue each year. The company earns $34.87 million in net income (profit) each year or $2.65 on an earnings per share basis. U.S. Physical Therapy employs 4,600 workers across the globe.View Additional Information About U.S. Physical Therapy.

What is U.S. Physical Therapy's official website?

The official website for U.S. Physical Therapy is http://www.usph.com/.

How can I contact U.S. Physical Therapy?

U.S. Physical Therapy's mailing address is 1300 WEST SAM HOUSTON PARKWAY SUITE 300, HOUSTON TX, 77042. The company can be reached via phone at 713-297-7000 or via email at [email protected]


MarketBeat Community Rating for U.S. Physical Therapy (NYSE USPH)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  202 (Vote Outperform)
Underperform Votes:  300 (Vote Underperform)
Total Votes:  502
MarketBeat's community ratings are surveys of what our community members think about U.S. Physical Therapy and other stocks. Vote "Outperform" if you believe USPH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe USPH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/23/2020 by MarketBeat.com Staff

Featured Article: What is a Call Option?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel